Condition 1: sexual function. Condition 2: sexual self-expression.
Conditions
Interventions
Intervention 1: First intervention group: receiving vitamin D supplement (one capsule of 1000 international units, made in Iran or imported, depending on availability and approval by the Food and Drug
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: - Age between 18 and 40 years - At least 1 month has passed since the start of sexual intercourse and a maximum of 4 months after childbirth (before the start of complementary feeding) - Active and exclusive breastfeeding - Having sex at least once a month - No history of chronic diseases (diabetes, thyroid, epilepsy, etc.) - No use of hormonal or antidepressant medications in the past 3 months - Consent to participate in the study and completion of the informed consent form
Exclusion criteria
Exclusion criteria: - Allergy to prescribed supplements - Taking medications that affect sexual function and self-expression, such as blood pressure reducers, antihistamines, H2 blockers, barbiturates - Taking birth control pills - Taking supplements containing synbiotics, probiotics, or vitamin D (except for the usual doses of pregnancy supplements if taken continuously during pregnancy and no more) for at least 4-6 weeks prior - Taking any new medications that affect mood or sexual function
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function of lactating women. Timepoint: At the beginning of the study and 8 weeks after starting the supplements. Method of measurement: The Female Sexual Function Index (FSFI) questionnaire.;Sexual self-expression of lactating women. Timepoint: At the beginning of the study and 8 weeks after starting the supplements. Method of measurement: Hulbert Index of Sexual Assertiveness questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Naeemi
Yasouj University of Medical Sciences
Outcome results
None listed